Victory Capital Management Inc. Acquires 9,215 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Victory Capital Management Inc. increased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 25.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 45,834 shares of the company's stock after acquiring an additional 9,215 shares during the quarter. Victory Capital Management Inc.'s holdings in Bath & Body Works were worth $1,777,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Golden State Wealth Management LLC bought a new position in Bath & Body Works during the 4th quarter worth about $26,000. SRS Capital Advisors Inc. raised its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after buying an additional 329 shares during the last quarter. True Wealth Design LLC lifted its stake in Bath & Body Works by 5,270.0% in the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company's stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. UMB Bank n.a. lifted its stake in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Stock Up 0.5 %

Shares of BBWI traded up $0.14 during trading hours on Friday, hitting $30.24. The company had a trading volume of 3,890,108 shares, compared to its average volume of 4,243,720. The business has a fifty day moving average of $35.83 and a 200-day moving average of $33.93. The firm has a market cap of $6.48 billion, a price-to-earnings ratio of 7.38, a PEG ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 12 month low of $26.21 and a 12 month high of $52.99.

Remove Ads

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $2.79 billion for the quarter, compared to analysts' expectations of $2.78 billion. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its board has authorized a stock repurchase program on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were paid a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.65%. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on BBWI. Deutsche Bank Aktiengesellschaft increased their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Barclays reduced their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating for the company in a research note on Monday, March 3rd. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Telsey Advisory Group reissued an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a research report on Friday, January 10th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of "Moderate Buy" and an average price target of $45.06.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.